Prostate Cancer - Results from #19820

Androgen deprivation therapy for prostate cancer: Long-term safety and patient outcomes - Abstract August 29, 2014

Factors influencing the acceptance of transrectal ultrasound-guided prostate biopsies - Abstract August 29, 2014

Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-Year outcomes - Abstract August 29, 2014

Comparison of MR-US fusion-guided prostate biopsies obtained from axial and sagittal approaches - Abstract August 29, 2014

Histopathological screening for prostate carcinoma: Is a benign biopsy a negative biopsy? - Abstract August 29, 2014

Cytotoxic chemotherapy in the contemporary management of metastatic prostate cancer - Abstract August 29, 2014

Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence - Abstract August 28, 2014

Radiation dose to rectum in high-dose-rate brachytherapy with a single implant and two fractions for prostate cancer, and its prediction by prostate volume - Abstract August 28, 2014

Trans-perineal prostate biopsy: Template-guided or free-hand? - Abstract August 28, 2014

Sarcomatoid carcinoma of the prostate: ERG fluorescence in situ hybridization confirms epithelial origin - Abstract August 28, 2014

Does the multidisciplinary approach improve oncological outcomes in men undergoing surgical treatment for prostate cancer? - Abstract August 28, 2014

Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer - Abstract August 28, 2014

Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer - Abstract August 28, 2014

Prostate cancer: Diagnosis, parametric imaging and standardized report - Abstract August 28, 2014

Metastatic small cell carcinoma of the prostate: Population-based analysis of patient characteristics and treatment paradigms - Abstract August 27, 2014

Abiraterone acetate in metastatic castration-resistant prostate cancer: A retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole - Abstract August 27, 2014

Generalizability of established prostate cancer risk variants in men of African ancestry - Abstract August 27, 2014

Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring - Abstract August 26, 2014

Correlation between dynamic contrast-enhanced MRI and quantitative histopathologic microvascular parameters in organ-confined prostate cancer - Abstract August 26, 2014

Prostate health index vs %free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: Systematic review and meta-analysis - Abstract August 26, 2014

Page 992 of 1436